W. Mraz
- Transplantation top 2%
- Renal Transplantation Outcomes and Treatments 5
-
- Diabetes, Cardiovascular Risks, and Lipoproteins 4
- Hematology top 5%
- Platelet Disorders and Treatments 2
- Nephrology top 10%
- Immunology top 10%
-
- Pharmacological Effects and Toxicity Studies 5
-
- Glycosylation and Glycoproteins Research 4
-
- Metabolism and Genetic Disorders 4
-
- Lipid metabolism and disorders 3
-
- Blood properties and coagulation 2
- Co-authors
- Horst JatzkewitzWolfgang KöenigErhard HillerG. BrehmWalter LehmacherErnst HollerU. JehnHannelore Loewel
- Partner nations
- GermanyUnited StatesAustria
In The Last Decade
W. Mraz
23 papers receiving 987 citations
Peers
Comparison fields: 5 of 89
- Transplantation 132
- Endocrinology, Diabetes and Metabolism 273
- Hematology 173
- Nephrology 79
- Immunology 220
Countries citing papers authored by W. Mraz
This map shows the geographic impact of W. Mraz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by W. Mraz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites W. Mraz more than expected).
Fields of papers citing papers by W. Mraz
This network shows the impact of papers produced by W. Mraz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by W. Mraz. The network helps show where W. Mraz may publish in the future.
Co-authorship network
The 25 scholars most cited alongside W. Mraz, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2008 | 0 | |
| 2 | 2005 | 3 | |
| 3 | 2004 | 109 | |
| 4 | 2001 | 88 | |
| 5 | 1996 | 107 | |
| 6 | 1992 | 2 | |
| 7 | Impact of imipenem/cilastatin on cyclosporine metabolism and excretion. | 1992 | 1 |
| 8 | 1992 | 82 | |
| 9 | 1989 | 155 | |
| 10 | 1989 | 173 | |
| 11 | Reduction of cyclosporin (CSA) nephrotoxicity by imipenem/cilastatin after kidney transplantation in rats. | 1989 | 7 |
| 12 | Analysis of cyclosporin A (CsA) concentrations by fluorescence polarization immunoassay (FPIA): comparison with radio immunoassay (RIA) and liquid chromatography (HPLC). | 1989 | 5 |
| 13 | Concomitant immunosuppressive and antibiotic therapy--reduction of cyclosporine A blood levels due to treatment with imipenem/cilastatin. | 1987 | 8 |
| 14 | 1983 | 27 | |
| 15 | 1980 | 38 | |
| 16 | 1979 | 68 | |
| 17 | 1978 | 23 | |
| 18 | 1976 | 34 | |
| 19 | 1976 | 6 | |
| 20 | 1974 | 24 |
About W. Mraz
W. Mraz is a scholar working on Transplantation, Clinical Biochemistry, Endocrinology, Diabetes and Metabolism, Pediatrics, Perinatology and Child Health and Pharmacy, having authored 24 papers that have together received 1.0k indexed citations. Recurring topics across this work include Renal Transplantation Outcomes and Treatments (5 papers), Pharmacological Effects and Toxicity Studies (5 papers), Glycosylation and Glycoproteins Research (4 papers), Metabolism and Genetic Disorders (4 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (4 papers), Lipid metabolism and disorders (3 papers), Blood properties and coagulation (2 papers) and Platelet Disorders and Treatments (2 papers). The work is most often cited by research in Transplantation (132 citations), Endocrinology, Diabetes and Metabolism (273 citations), Hematology (173 citations), Nephrology (79 citations) and Immunology (220 citations). W. Mraz has collaborated with scholars based in Germany, United States and Austria. Frequent co-authors include Horst Jatzkewitz, Wolfgang Köenig, Erhard Hiller, G. Brehm, Walter Lehmacher, Ernst Holler, U. Jehn, Hannelore Loewel, Christa Meisinger and Günter Schwarzmann. Their work appears in journals such as Blood, Cancer, FEBS Letters, Biological Chemistry and European Journal of Biochemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.